The present invention relates to tricyclic quinoline and quinoxaline derivatives, to a pharmaceutical composition containing such compounds, to their use as modulators, especially agonists or partial agonists, of the 5-HT2C receptor, their use for preparing a medicament for the prevention or treatment of conditions and disorders which respond to the modulation of 5-HT2C receptor, and to a method for preventing or treating conditions and disorders which respond to the modulation of 5-HT2C receptor.
本发明涉及
三环喹啉和
喹喔啉衍
生物,涉及含有此类化合物的药物组合物,涉及它们作为 5-HT2C 受体调节剂(尤其是激动剂或部分激动剂)的用途,涉及它们用于制备预防或治疗对 5-HT2C 受体调节有反应的病症和紊乱的药物,还涉及一种预防或治疗对 5-HT2C 受体调节有反应的病症和紊乱的方法。